Merck halts study of "ineffective" HIV vaccine
472915
Merck & Co has halted testing of its experimental HIV vaccine -- long considered one of the most promising vaccines in development -- after a monitoring board found it was ineffective, the company said on Friday.
312875
Arena Pharmaceuticals, Inc.   ARNA.O said on Monday that Merck & Co. Inc. MRK.N has   pulled out of a partnership to develop an experimental drug for   atherosclerosis after results from a mid-stage clinical trail.
108019
Merck announced that it would stop selling Vioxx, because a study found that it doubled patients' risk of heart attack and strokes.
380901
Merck said it voluntarily pulled the drug after new data from a clinical trial found an increased risk of heart attack and stroke.
392390
Brazilian health officials stopped the use of Chiron's vaccine against measles, mumps and rubella, after a high number of children experienced serious reactions.
741757
TRENTON, N.J. - In a disappointing setback, a promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study.
522767
Arena Pharmaceuticals, Inc.   said on Monday that Merck & Co. Inc.  has  pulled out of a partnership to develop an experimental drug for  atherosclerosis after results from a mid-stage clinical trail.
657110
Decode Genetics Inc. said on Thursday it was halting its late-stage clinical trial program for an experimental oral heart attack drug after a formulation problem with the tablets cropped up.
465386
An experimental HIV drug from Merck &amp; Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.
338808
Researchers in the US have halted a government study involving a non-steroidal anti-inflammatory drug known as Naproxen, brand Aleve, after data indicated possible increased heart risks associated with the painkiller.
421836
Merck & Co.  on Friday said U.S. regulators have decided not to approve the company's experimental arthritis drug, the successor to its recalled Vioxx pill, until more safety and effectiveness data are obtained.
628834
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market after a study showed it  doubled the risk of heart attack and stroke, a move that sent  its shares plunging and erased $25 billion from its market  value.
453830
The first anti-AIDS vaginal gel to make it through late-stage testing failed to stop HIV infection in a study of 6,000 South African women
672526
Merck & Co. MRK.N said on Friday it   would delay seeking approval for a combination pill designed to   lower "bad" cholesterol, increase "good" cholesterol and avoid   a common side effect of one of the ingredients.
261328
WASHINGTON -- Merck &amp; Co., which stopped selling its blockbuster Vioxx drug due to heart problems caused by the painkiller, manipulated the design of a key study for a new painkiller to minimize its cardiovascular risks and increase chances of approval, a federal whistle-blower says.
37552
The drug giant Merck suspends trials on an HIV vaccine that was regarded as one of the most promising.
195152
Merck &amp; Co. yesterday pulled the blockbuster pain medicine Vioxx off the market, announcing that a new company-sponsored study showed the drug doubled the risk